Back to clinical trials
RecruitingObservational
Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers
NCT ID: NCT03413982Sponsor: University of Kansas Medical CenterLast updated: 2026-03-10
Summary
The purpose of this study is to create a registry, which is a "bank" of information about patients who have had similar medical conditions and treatments. The registry will be used by researchers to learn more about long term outcome of patients with bladder cancer, how bladder cancer tissues are related to tumor development, recurrence and survival.
Arms & interventions
- OtherRegistry
Patient registry
Outcome measures
Primary
Blood, urine and tissue characteristics of bladder cancer patients
Samples will be collected over a 24 month period for patients to build a biorepository for future research on how they are related to tumor development, recurrence and survival.
Time frame: 24 months
Eligibility criteria
Sex: AllAge: 18 Years and olderHealthy volunteers: No
Inclusion Criteria:
* Patients who present to clinic with presumed bladder cancer or have a diagnosis of bladder cancer are eligible to participate
* Patients can participate in any additional research studies during the patients' participation within this protocol.
Exclusion Criteria:
* Patients who do not have presumed bladder cancer will not be eligible
Study locations (1)
University of Kansas Medical Center
Kansas City, Kansas, 66160